Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

2

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Emergence of CTX-M-9 Extended-Spectrum β-Lactamase-Producing Enterobacter cloacae Isolates

Original article

Annals of Clinical Microbiology (Ann Clin Microbiol) 2005 June Volume 8, Issue 1, pages 57-65.


https://doi.org/10.5145/ACM.2005.08.1.57

Emergence of CTX-M-9 Extended-Spectrum β-Lactamase-Producing Enterobacter cloacae Isolates

Yoo Rah Hong1, Hoyen Yu1, Il Kwon Bae2, Su Bong Kwon2, Seok Hoon Jeong2,3*, Hyun Joo Kim3, Youn Hwa Kim3, and Sang Hee Lee4
Departments of Pediatrics1, and Laboratory Medicine2, Kosin University College of Medicine, Busan; Department of Quality Improvement3, Kosin University Gospel Hospital, Busan; Department of Biological Science4, Myongji University, Seoul, Korea

Abstract

Background: The aim of this study is to assess the prevalence and to investigate the molecular epidemiology of Ambler class A extended-spectrum β-lactamase (ESBL)-producing Enterobacter cloacae isolates in a university hospital in Busan, Korea.

Methods: Non-duplicated clinical isolates of E. cloacae from patients admitted in Kosin University Gospel Hospital were collected during the period from January through September, 2003. ESBL-production was examined by the double-disk synergy test (DDST) and the transferability of cefotaxime-resistance by conjugation. MICs of β-lactam antibiotics were determined by the agar dilution method and Ambler class A ESBL genes were searched by PCR amplification. Enterobacterial repetitive intergenic consensus (ERIC) PCR was performed to investigate epidemiological relationships among blaCTX-M-9 gene-carrying E. cloacae isolates.

Results: Antimicrobial resistance rates of E. cloacae isolates (n=148) to ceftazidime, cefotaxime, and aztreonam were 50.0%, 29.6%, and 48.0%, respectively. Among 50 E. cloacae isolates intermediate or resistant to more than one expanded-spectrum β-lactam agent, 41 (27.7%) showed positive results in DDST; of these 41 isolates, 1 was found to carry blaTEM-52 gene, 16 carried blaSHV-12 gene, 4 blaCTX-M-9 gene, and 19 both blaSHV-12 and blaCTX-M-9 genes. The 23 E. cloacae isolates carrying blaCTX-M-9 gene showed 9 different profiles by ERIC PCR.

Conclusion: ESBL-producing E. cloacae was not uncommon in a university hospital in Busan, Korea. The commonest types of ESBLs produced by E. cloacae isolates were SHV-12 and CTX-M9. CTX-M-9 ESBL-producing E. cloacae isolates showed diverse ERIC-PCR profiles, indicating that they were not originated from a common source. (Korean J Clin Microbiol 2005;8(1):1-9)

Keywords

Enterobacter cloacae, SHV-12, CTX-M-9, Enterobacterial repetitive intergenic consensus, Polymerase chain reaction